These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1948757)

  • 21. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 23. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 25. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 26. [Initial evaluation of aluminum concentrations in patients with nephropathy and undergoing hemodialysis at the Miguel Pérez Carreño Hospital and the University Hospital of Caracas (Venezuela)].
    Parra OE; Navarro JA; de Ardila M; Weissinger J; Domínguez J; Gutiérrez LE; Carlini R; Mendoza JA; Salgado OJ; Romero RA
    Invest Clin; 1989; 30(4):193-203. PubMed ID: 2488708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemistry of desferrioxamine chelation for aluminum overload in renal dialysis patients.
    Day JP; Ackrill P
    Ther Drug Monit; 1993 Dec; 15(6):598-601. PubMed ID: 8122301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition and management of aluminum intoxication in children.
    Tsuru N; Williams JL; Chan JC
    Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG; Danielson BG; Fellström B; Wikström B
    Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudo-porphyria cutanea tarda in patients with chronic renal insufficiency and in patients with renal transplants].
    Antonello A; Peserico A; Corsano A; Zannini G; Fagiolo U
    Minerva Chir; 1980 May; 35(10):775-7. PubMed ID: 7005735
    [No Abstract]   [Full Text] [Related]  

  • 33. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
    Bournerias F; Monnier N; Dufier JL; Réveillaud RJ
    Nephrologie; 1987; 8(1):27-9. PubMed ID: 3587485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The toxicity of aluminum in chronic renal failure].
    Sulková S; Válek A
    Cas Lek Cesk; 1986 Dec; 125(49):1500-4. PubMed ID: 3802139
    [No Abstract]   [Full Text] [Related]  

  • 35. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
    Wang G; Zhu P; Wang S
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):36-40. PubMed ID: 9275645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aluminum and iron deposition in dialysis patients].
    Kurihara S; Marumo F
    Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemoptysis and altered sensorium in a hemodialysis patient.
    Olivero JJ
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):77-8. PubMed ID: 8450006
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure.
    Verbeelen D; Smeyers-Verbeke J; van Hooff I; de Roy G
    J Trace Elem Electrolytes Health Dis; 1988 Jun; 2(2):67-72. PubMed ID: 2980801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients].
    Kiss D; Battegay M; Meier C; Lyrer A
    Schweiz Med Wochenschr; 1990 Mar; 120(9):295-8. PubMed ID: 2315655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aluminum kinetics in patients treated with hemodialysis or hemofiltration with sorbent recycling of ultrafiltrate.
    Shapiro WB; Schilb TP; Porush JG
    Trans Am Soc Artif Intern Organs; 1984; 30():342-6. PubMed ID: 6533906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.